AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
-19.44%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$146M
AUM Growth
+$146M
(-21%)
Cap. Flow
-$154M
Cap. Flow
% of AUM
-105.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$154M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
American Well
AMWL
$111M
| $57.4M | 39.29% |
6,300,773
| – | – |
|
2
Annexon
ANNX
$226M
| $36.4M | 24.9% |
1,954,978
| – | – |
|
|
RNTX
3
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $16.9M | 11.6% |
16,609,449
| – | – |
|
4
Akebia Therapeutics
AKBA
$833M
| $13.4M | 9.17% |
4,652,561
| – | – |
|
|
WHWK
5
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $11M | 7.53% |
374,785
-5,247,050
| -93% | -$154M |
|
6
Assembly Biosciences
ASMB
$190M
| $7.75M | 5.31% |
2,227,500
| – | – |
|
|
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.22M | 2.2% |
126,270
| – | – |
|